Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 2,021 shares at $15.07 ($31K) on 2022-09-09, disclosed to the SEC on 2022-09-12.
Scheduled sale ($31k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.13 | 1,221 | $18K | 60.5% |
| 2 | $15.07 | 800 | $12K | 39.5% |
| Total | $15.11 avg | 2,021 | $31K | 100% |
| Filing → |
| TRDA | SELL | 2023-08-04 | $771K | — | Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |